Stephen Willey
Stock Analyst at Stifel
(3.92)
# 616
Out of 5,090 analysts
126
Total ratings
43.01%
Success rate
13.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $26.69 | +49.87% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $105.63 | +8.87% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $1.80 | +511.11% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $93.29 | +33.99% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $69.56 | +85.45% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $102.52 | +12.17% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.98 | +126.13% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $204.00 | -28.92% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.56 | +96.63% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $44.36 | -7.57% | 19 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $13.07 | +114.23% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.37 | +264.96% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $5.42 | +269.00% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $18.09 | +93.48% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $8.18 | +1,122.49% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.31 | +205.34% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.20 | +158.24% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.55 | +628.86% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.51 | +164.90% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $45.01 | +37.75% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.53 | +62.75% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.95 | +515.38% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.07 | +13,813.04% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.26 | +829.20% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.40 | +185.71% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $458.12 | -73.15% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $81.68 | -42.46% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $53.40 | +104.12% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $20.74 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.92 | +190.40% | 5 | Feb 7, 2018 |
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $26.69
Upside: +49.87%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $105.63
Upside: +8.87%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.80
Upside: +511.11%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $93.29
Upside: +33.99%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $69.56
Upside: +85.45%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $102.52
Upside: +12.17%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.98
Upside: +126.13%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $204.00
Upside: -28.92%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.56
Upside: +96.63%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $44.36
Upside: -7.57%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $13.07
Upside: +114.23%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.37
Upside: +264.96%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.42
Upside: +269.00%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $18.09
Upside: +93.48%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $8.18
Upside: +1,122.49%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.31
Upside: +205.34%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.20
Upside: +158.24%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.55
Upside: +628.86%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.51
Upside: +164.90%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $45.01
Upside: +37.75%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.53
Upside: +62.75%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.95
Upside: +515.38%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.07
Upside: +13,813.04%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.26
Upside: +829.20%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.40
Upside: +185.71%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $458.12
Upside: -73.15%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $81.68
Upside: -42.46%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $53.40
Upside: +104.12%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $20.74
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.92
Upside: +190.40%